UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory

Therapeutic drug monitoring, 2024-10, Vol.46 (5), p.619-626

2024

Volltextzugriff (PDF)

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

Frontiers in pharmacology, 2023-02, Vol.14, p.1080117-1080117

2023

Volltextzugriff (PDF)

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus

Frontiers in genetics, 2022-05, Vol.13, p.869160-869160

2022

Volltextzugriff (PDF)

Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?

Therapeutic drug monitoring, 2014-02, Vol.36 (1), p.86-92

2014

Volltextzugriff (PDF)

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Stroke (1970), 2017-01, Vol.48 (1), p.159-166

2017

Volltextzugriff (PDF)

Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry

Therapeutic drug monitoring, 2020-06, Vol.42 (3), p.473-480

2020

Volltextzugriff (PDF)

Usage of renal function equations to guide prescribing in general medicine

New Zealand medical journal, 2013-09, Vol.126 (1383), p.97-99

2013

Volltextzugriff (PDF)

Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography–Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma

Therapeutic drug monitoring, 2018-12, Vol.40 (6), p.682-692

2018

Volltextzugriff (PDF)

Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects

British journal of clinical pharmacology, 2011-12, Vol.72 (6), p.985-989

2011

Volltextzugriff (PDF)

The effect of routine preoperative interruption of dabigatran therapy on coagulation parameters and dabigatran plasma levels in a mixed surgical population

Anaesthesia and intensive care, 2019-03, Vol.47 (2), p.183-188

2019

Volltextzugriff (PDF)

A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

Clinical microbiology and infection, 2022-03, Vol.28 (3), p.446.e1-446.e7

2022

Volltextzugriff (PDF)

Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand

British journal of clinical pharmacology, 2023-10, Vol.89 (10), p.3105-3115

2023

Volltextzugriff (PDF)

Four‐year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing

Internal medicine journal, 2023-11, Vol.53 (11), p.2123-2127

2023

Volltextzugriff (PDF)

Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?

Seminars in thrombosis and hemostasis, 2015-03, Vol.41 (2), p.195-207

Chin, Paul K L

2015

Volltextzugriff (PDF)

Changes in inpatient medicine prescribing during COVID‐19 lockdown

Internal medicine journal, 2023-06, Vol.53 (6), p.917-922

2023

Volltextzugriff (PDF)

A nationwide survey on therapeutic drug monitoring of anti‐tumour necrosis factor agents for inflammatory bowel disease

Internal medicine journal, 2021-03, Vol.51 (3), p.341-347

2021

Volltextzugriff (PDF)

Biological variation of thiopurine methyltransferase enzyme activity: when has a significant change taken place?

Annals of clinical biochemistry, 2013-09, Vol.50 (Pt 5), p.473-478

2013

Volltextzugriff (PDF)

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

Critical care (London, England), 2021-06, Vol.25 (1), p.201-25, Article 201

2021

Volltextzugriff (PDF)

Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup

Critical care (London, England), 2023-02, Vol.27 (1), p.56-56, Article 56

2023

Volltextzugriff (PDF)

A proposal for dose‐adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

British journal of clinical pharmacology, 2014-09, Vol.78 (3), p.599-609

2014

Volltextzugriff (PDF)

Clinical decision support in a hospital electronic prescribing system informed by local data: experience at a tertiary New Zealand centre

Internal medicine journal, 2020-10, Vol.50 (10), p.1225-1231

2020

Volltextzugriff (PDF)

Comment on: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”

Clinical pharmacokinetics, 2017-02, Vol.56 (2), p.207-208

2017

Volltextzugriff (PDF)

Letter by Chin et al Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”

Circulation (New York, N.Y.), 2014-11, Vol.130 (22), p.e194-e194

2014

Volltextzugriff (PDF)

A unified pharmacokinetic approach to individualized drug dosing

British journal of clinical pharmacology, 2012-03, Vol.73 (3), p.335-339

2012

Volltextzugriff (PDF)

Correlation Between Trough Plasma Dabigatran Concentrations and Estimates of Glomerular Filtration Rate Based on Creatinine and Cystatin C

Drugs in R&D, 2014-06, Vol.14 (2), p.113-123

2014

Volltextzugriff (PDF)

1 – 25 von 388

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(348)
Mit Volltextzugriff
(308)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(286)
Life Sciences & Biomedicine
(232)
Humans
(167)
Male
(81)
Female
(74)
Biological And Medical Sciences
(61)
Animals
(52)
Medical Sciences
(52)
Middle Aged
(49)
Adult
(44)
Aged
(42)
Physical Sciences
(42)
General & Internal Medicine
(36)
Pharmacology & Pharmacy
(35)
Oncology
(34)
Medicine, General & Internal
(30)
Mice
(28)
Science & Technology - Other Topics
(25)
Patients
(23)
Multidisciplinary Sciences
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus

Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry

Usage of renal function equations to guide prescribing in general medicine

Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography–Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma

Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects

The effect of routine preoperative interruption of dabigatran therapy on coagulation parameters and dabigatran plasma levels in a mixed surgical population

A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand

Four‐year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing

Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?

Changes in inpatient medicine prescribing during COVID‐19 lockdown

A nationwide survey on therapeutic drug monitoring of anti‐tumour necrosis factor agents for inflammatory bowel disease

Biological variation of thiopurine methyltransferase enzyme activity: when has a significant change taken place?

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup

A proposal for dose‐adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

Clinical decision support in a hospital electronic prescribing system informed by local data: experience at a tertiary New Zealand centre

Comment on: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”

Letter by Chin et al Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”

A unified pharmacokinetic approach to individualized drug dosing

Correlation Between Trough Plasma Dabigatran Concentrations and Estimates of Glomerular Filtration Rate Based on Creatinine and Cystatin C

Aktive Filter

Suchergebnisse filtern